Navigation Links
Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
Date:11/9/2007

BIRMINGHAM, Ala. and EXTON, Pa., Nov. 9 /PRNewswire-USNewswire/ -- Southern Research Institute and Absorption Systems, LP today announced that they have expanded their joint marketing agreement to allow Absorption Systems to represent Southern Research in European biotechnology and pharmaceutical markets. Ten months ago, the two organizations announced that they had signed a joint marketing agreement to collaborate in marketing contract research services in the areas of toxicology and bioanalytical services to biotechnology and pharmaceutical clients in the U.S.

The agreement expands this partnership so Absorption Systems will provide marketing and sales representation of Southern Research in Europe. Both companies will continue to provide critical preclinical contract research support to the biotechnology and pharmaceutical industries. Financial terms of the agreement were not announced.

"Our international business has expanded dramatically in the past 18 months, so this agreement with Absorption Systems will allow us to enhance our support to those clients, while continuing to expand our geographic reach," said Chaarles G. Fogelgren, director of Business Operations for the Drug Development Division at Southern Research.

"We are excited about expanding our relationship with Southern Research. Adding their capabilities in toxicology, cancer efficacy and anti-infectives to our capabilities in ADME and bioanalysis will provide a better outsourcing solution for our clients," said Patrick Dentinger, president and CEO of Absorption Systems.

The European sales and marketing representation also signals an expansion of Southern Research's dedicated sales force. In the past year, Southern Research has established a U.S.-based geographic sales force (http://www.southernresearch.org/bd-territories.html) and is moving to expand upon this success.

About Absorption Systems, LP

Founded in 1996, Absorption Systems, LP (ASLP) focuses on performing assays that can predict the Absorption, Distribution, Metabolism, and Excretion (ADME) of small molecules using a variety of in vitro, in situ, and in vivo models. ASLP supports these assays with state-of-the-art bioanalytical capabilities and preclinical formulation services. For more information, visit http://www.absorption.com.

About Southern Research Institute

Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and development. To date, Southern Research has discovered a record six cancer drugs that have received FDA-approval, with another six compounds currently in late-stage preclinical development or clinical trials. Southern Research has evaluated 50 percent of all other FDA-approved cancer drugs currently on the market. For more information, please visit http://www.SouthernResearch.org.

Media Contacts

Rhonda Jung 205-581-2317

Southern Research

jung@southernresearch.org

Risa Burgess 781-684-0770

Schwartz Communications

southern@schwartz-pr.com


'/>"/>
SOURCE Southern Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one ... of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has ... add Target to its list of well-respected retailers. This list includes such fine ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):